Search Climate Insights Directory

This report by the Climate Policy Initiative and the Amazon 2030 project analyzes the regulatory and institutional barriers hindering biodiversity-based biotechnology in Brazil, with a specific focus on the Amazon region. It identifies the Access and Benefit-Sharing (ABS) framework as a primary obstacle to innovation and investment, and suggests that the forthcoming National Bioeconomy Development Plan (PNDBIO) is a critical opportunity to integrate biotechnology into the national strategy.

This policy brief examines the international governance of biosafety, focusing on the 2000 Cartagena Protocol on Biosafety. It details the history of modern biotechnology, the tensions between exporting and importing nations regarding genetically modified organisms (GMOs), and the mechanisms used to manage the transboundary movement of living modified organisms (LMOs) to protect biodiversity and human health.

This policy brief outlines the international governance of biodiversity, focusing on the Convention on Biological Diversity (CBD) and its associated protocols. It details the shift from species-based to area-based conservation, the challenges of ensuring fair benefit-sharing from genetic resources, and the regulatory complexities introduced by emerging technologies like synthetic biology and digital sequence information (DSI). The document emphasizes the urgency of moving away from "business as usual" to reverse biodiversity loss and achieve sustainable development goals.

An open letter from Friends of the Earth Africa and various NGOs addressed to the Prime Minister of Denmark, protesting statements made by Minister for Development Cooperation Christian Friis Bach. The letter rejects the imposition of failed development models from developed nations and asserts Africa's right to food sovereignty and sustainable, self-determined development.

This research paper argues that African countries, particularly within the SADC region, should adopt biotechnology and genetic modification to combat food insecurity and climate-change-induced droughts. The author contends that current regulatory stances in Africa are overly influenced by external pressures from the European Union and the Cartagena Protocol, leading to 'regulatory overkill' that may conflict with World Trade Organization (WTO) rules and hinder the timely delivery of food relief.

This report analyzes the adoption and impact of genetically modified organisms (GMOs) in Argentine agriculture from the 1990s to 2003. It details the rapid expansion of glyphosate-tolerant soybean, the regulatory framework managed by CONABIA, and the socio-economic shifts resulting from structural reforms and technological intensification. The document evaluates the distribution of benefits between producers and multinational seed companies, the environmental effects of the 'no-till' (siembra directa) system, and the challenges posed by illegal seed markets ('bolsa blanca').

This briefing analyzes the legal arguments and international law frameworks relevant to the WTO dispute 'EC – Biotech', specifically focusing on the definition of risk assessments (RA) under the SPS Agreement and the potential influence of the Cartagena Protocol on Biosafety.

In this commentary to Nathan Gardels, Amory Lovins discusses the unintended consequences and existential risks associated with four powerful technologies: nuclear fission, genetic manipulation, nanotechnology, and artificial intelligence. Lovins argues that the pursuit of technological possibility without wisdom or feedback mechanisms poses a grave threat to humanity and suggests that safer, more biologically informed alternatives often exist.